(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (JJ molecular) (NNS aberrations)) (PP (IN of) (NP (NN Wnt) (NN pathway)))))) (VP (VBZ gladiators) (PP (IN in) (NP (NP (JJ colorectal) (NN cancer)) (PP (IN in) (NP (DT the) (NN Kashmiri) (NN population))))))) (. .)))
(S1 (S (S (S (NP (NP (DT The) (NP (NN development)) (CC and) (NP (NN progression))) (PP (IN of) (NP (NP (JJ colorectal) (NN cancer)) (PRN (-LRB- -LRB-) (NP (NN CRC)) (-RRB- -RRB-))))) (VP (VBZ is) (NP (DT a) (JJ multi-step) (NN process)))) (, ,) (CC and) (S (NP (NP (DT the) (NN Wnt) (NNS pathways)) (PP (IN with) (NP (PRP$ its) (NP (CD two) (JJ molecular) (NNS gladiators) (NP (NP (NP (JJ adenomatous) (NN polyposis) (NN coli)) (PRN (-LRB- -LRB-) (NP (NN APC)) (-RRB- -RRB-))) (CC and) (NP (NN beta-catenin))))))) (VP (VBZ plays) (NP (DT an) (JJ important) (NN role)) (PP (IN in) (S (VP (VBG transforming) (NP (DT a) (JJ normal) (NN tissue)) (PP (IN into) (NP (DT a) (JJ malignant) (NN one))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD aimed) (S (S (VP (TO to) (VP (VB investigate) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (NNS aberrations)) (PP (IN in) (NP (DT the) (NP (NP (NN APC)) (CC and) (NP (NN beta-catenin))) (NNS genes))))) (PP (IN in) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NP (NN CRC)) (PP (IN in) (NP (DT the) (JJ Kashmir) (NN valley))))))))))) (, ,) (CC and) (S (VP (TO to) (VP (VB correlate) (NP (PRP it)) (PP (IN with) (NP (JJ various) (JJ clinicopathological) (NNS variables))))))))) (. .)))
(S1 (S (NP (PRP We)) (VP (VBD examined) (NP (NP (NP (DT the) (JJ paired) (NN tumour)) (CC and) (NP (JJ normal-tissue) (NNS specimens))) (PP (IN of) (NP (CD 86) (NN CRC) (NNS patients))) (PP (IN for) (NP (NP (DT the) (NN occurrence)) (PP (IN of) (NP (NP (NNS aberrations)) (PP (IN in) (NP (NP (NP (NP (DT the) (NN mutation) (NN cluster) (NN region)) (PRN (-LRB- -LRB-) (NP (NN MCR)) (-RRB- -RRB-))) (PP (IN of) (NP (DT the) (NN APC) (NN gene)))) (CC and) (NP (NP (NN exon) (CD 3)) (PP (IN of) (NP (DT the) (NN beta-catenin) (NN gene))))))))))) (PP (IN by) (NP (NP (NP (NN polymerase) (NN chain) (NN reaction-single-strand) (NN conformation) (NN polymorphism)) (PRN (-LRB- -LRB-) (NP (NN PCR-SSCP)) (-RRB- -RRB-))) (CC and/or) (NP (NN PCR-direct) (NN sequencing))))) (. .)))
(S1 (S (S (NP (NP (NN Analysis)) (PP (IN of) (NP (NP (NN promoter) (NN hypermethylation)) (PP (IN of) (NP (DT the) (NN APC) (NN gene)))))) (VP (VBD was) (ADVP (RB also)) (VP (VBN carried) (PRT (RP out)) (S (VP (VBG using) (NP (NP (JJ methylation-specific) (NN PCR)) (PRN (-LRB- -LRB-) (NP (NN MS-PCR)) (-RRB- -RRB-)))))))) (. .)))
(S1 (S (S (NP (NP (DT The) (JJ overall) (NN mutation) (NN rate)) (PP (IN of) (NP (NP (DT the) (NN MCR)) (PP (IN of) (NP (DT the) (NN APC) (NN gene))) (PP (IN among) (NP (CD 86) (NN CRC) (NNS cases)))))) (VP (VBD was) (NP (NP (CD 12.8)) (PP (IN per) (NP (NN cent)))) (PRN (-LRB- -LRB-) (QP (CD 11) (IN of) (CD 86)) (-RRB- -RRB-)))) (. .)))
(S1 (S (S (NP (NP (NN Promoter) (NN hypermethylation)) (PP (IN of) (NP (NN APC)))) (VP (VBD was) (VP (VBN observed) (PP (IN in) (NP (NP (NP (NP (CD 54.65)) (PP (IN per) (NP (NN cent)))) (PRN (-LRB- -LRB-) (QP (CD 47) (IN of) (CD 86)) (-RRB- -RRB-))) (PP (IN of) (NP (NNS cases)))))))) (. .)))
(S1 (S (ADVP (RB Furthermore)) (, ,) (NP (PRP we)) (VP (VBD found) (NP (NP (NP (DT a) (JJ significant) (NN association)) (PP (IN between) (NP (NP (NN tumour) (NN location)) (, ,) (NP (NN tumour) (NN grade)) (CC and) (NP (NN node) (NN status))))) (CC and) (NP (NP (DT the) (NN methylation) (NN status)) (PP (IN of) (NP (DT the) (NN APC) (NN gene))))) (PRN (-LRB- -LRB-) (S (NP (NN p) (CD <)) (VP (JJ =) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .)))
(S1 (S (SBAR (IN Although) (S (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS mutations)) (PP (IN in) (NP (NP (NP (DT the) (NP (NN APC)) (CC and) (NP (NN beta-catenin))) (NNS genes)) (PP (IN in) (NP (PRP$ our) (NN CRC) (NNS cases)))))))) (VP (VBD was) (ADJP (RB very) (JJ low))))) (, ,) (NP (DT the) (NN study)) (VP (VBZ confirms) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NP (JJ epigenetic) (NN gene) (NN silencing)) (PP (IN of) (NP (NP (NP (DT the) (JJ pivotal) (JJ molecular) (NN gladiator)) (, ,) (NP (NN APC)) (, ,)) (PP (IN of) (NP (DT the) (NN Wnt) (NN pathway))))))) (PP (IN in) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (NN CRC)) (PP (IN in) (NP (DT the) (NN Kashmiri) (NN population))))))))) (. .)))
